269 related articles for article (PubMed ID: 26330510)
1. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
[TBL] [Abstract][Full Text] [Related]
2. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
Morrison CS; Fichorova R; Chen PL; Kwok C; Deese J; Yamamoto H; Anderson S; Chipato T; Salata R; Doncel GF
AIDS Res Hum Retroviruses; 2018 Oct; 34(10):889-899. PubMed ID: 30047279
[TBL] [Abstract][Full Text] [Related]
3. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
Morrison C; Fichorova RN; Mauck C; Chen PL; Kwok C; Chipato T; Salata R; Doncel GF
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):109-17. PubMed ID: 24413042
[TBL] [Abstract][Full Text] [Related]
4. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
[TBL] [Abstract][Full Text] [Related]
5. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission.
van de Wijgert JH; Verwijs MC; Turner AN; Morrison CS
AIDS; 2013 Aug; 27(13):2141-53. PubMed ID: 23660575
[TBL] [Abstract][Full Text] [Related]
6. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
7. Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.
Morrison CS; Chen PL; Yamamoto H; Gao X; Chipato T; Anderson S; Barbieri R; Salata R; Doncel GF; Fichorova RN
J Acquir Immune Defic Syndr; 2020 May; 84(1):85-91. PubMed ID: 31985699
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception and the risk of HIV acquisition.
Morrison CS; Richardson BA; Mmiro F; Chipato T; Celentano DD; Luoto J; Mugerwa R; Padian N; Rugpao S; Brown JM; Cornelisse P; Salata RA;
AIDS; 2007 Jan; 21(1):85-95. PubMed ID: 17148972
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
Thurman A; Chandra N; Schwartz JL; Brache V; Chen BA; Asin S; Rollenhagen C; Herold BC; Fichorova RN; Hillier SL; Weiner DH; Mauck C; Doncel GF
AIDS Res Hum Retroviruses; 2019 Sep; 35(9):853-864. PubMed ID: 30997816
[TBL] [Abstract][Full Text] [Related]
11. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells.
Masson L; Salkinder AL; Olivier AJ; McKinnon LR; Gamieldien H; Mlisana K; Scriba TJ; Lewis DA; Little F; Jaspan HB; Ronacher K; Denny L; Abdool Karim SS; Passmore JA
Immunology; 2015 Dec; 146(4):557-67. PubMed ID: 26302175
[TBL] [Abstract][Full Text] [Related]
12. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.
Achilles SL; Meyn LA; Mhlanga FG; Matubu AT; Stoner KA; Beamer MA; Chirenje ZM; Hillier SL
Am J Reprod Immunol; 2020 Sep; 84(3):e13287. PubMed ID: 32533883
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.
Mauck C; Chen PL; Morrison CS; Fichorova RN; Kwok C; Chipato T; Salata RA; Doncel GF
AIDS Res Hum Retroviruses; 2016 May; 32(5):443-51. PubMed ID: 26650885
[TBL] [Abstract][Full Text] [Related]
14. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
15. Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.
Guthrie BL; Introini A; Roxby AC; Choi RY; Bosire R; Lohman-Payne B; Hirbod T; Farquhar C; Broliden K
J Acquir Immune Defic Syndr; 2015 May; 69(1):1-10. PubMed ID: 25622059
[TBL] [Abstract][Full Text] [Related]
16. Differential Elevation of Inflammation and CD4
Omollo K; Lajoie J; Oyugi J; Wessels JM; Mwaengo D; Kimani J; Kaushic C; Fowke KR
Front Immunol; 2020; 11():598307. PubMed ID: 33717049
[TBL] [Abstract][Full Text] [Related]
17. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.
Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M
Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477
[TBL] [Abstract][Full Text] [Related]
18. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
19. Persistent, Asymptomatic Colonization with
Happel AU; Gasper M; Balle C; Konstantinus I; Gamieldien H; Dabee S; Gill K; Bekker LG; Passmore JS; Jaspan HB
Microbiol Spectr; 2022 Apr; 10(2):e0162621. PubMed ID: 35348351
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa.
Noguchi LM; Marrazzo JM; Richardson B; Hillier SL; Balkus JE; Palanee-Phillips T; Nair G; Panchia R; Piper J; Gomez K; Ramjee G; Chirenje ZM
Front Reprod Health; 2021 Jul; 3():. PubMed ID: 35669097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
